Connection

Youchun Wang to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Youchun Wang has written about Spike Glycoprotein, Coronavirus.
Youchun Wang
Connection Strength
0.431
Spike Glycoprotein, Coronavirus
  1. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
    View in: PubMed
    Score: 0.101
  2. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
    View in: PubMed
    Score: 0.099
  3. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
    View in: PubMed
    Score: 0.027
  4. Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants. Cell Res. 2021 10; 31(10):1126-1129.
    View in: PubMed
    Score: 0.027
  5. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021 10; 31(10):1130-1133.
    View in: PubMed
    Score: 0.027
  6. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
    View in: PubMed
    Score: 0.026
  7. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021 03 27; 6(1):134.
    View in: PubMed
    Score: 0.026
  8. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
    View in: PubMed
    Score: 0.025
  9. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020 08; 584(7819):115-119.
    View in: PubMed
    Score: 0.024
  10. Establishment of a reference panel for the detection of anti-SARS-CoV antibodies. Biologicals. 2007 Jun; 35(3):203-10.
    View in: PubMed
    Score: 0.010
  11. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
    View in: PubMed
    Score: 0.007
  12. Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants. Virol Sin. 2021 Oct; 36(5):934-947.
    View in: PubMed
    Score: 0.007
  13. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
    View in: PubMed
    Score: 0.007
  14. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
    View in: PubMed
    Score: 0.007
  15. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
    View in: PubMed
    Score: 0.006
  16. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.